A phase I/IIa trial of ATX 101 in patients with superficial bladder cancer
Latest Information Update: 12 Oct 2016
Price :
$35 *
At a glance
- Drugs ATX 101 (Primary)
- Indications Bladder cancer
- Focus Adverse reactions
- 12 Oct 2016 New trial record
Latest Information Update: 12 Oct 2016